nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—SLC12A1—Furosemide—dilated cardiomyopathy	0.15	0.177	CbGbCtD
Hydroflumethiazide—CA14—Furosemide—dilated cardiomyopathy	0.117	0.138	CbGbCtD
Hydroflumethiazide—CA5B—Furosemide—dilated cardiomyopathy	0.0967	0.115	CbGbCtD
Hydroflumethiazide—CA7—Furosemide—dilated cardiomyopathy	0.0967	0.115	CbGbCtD
Hydroflumethiazide—CA9—Furosemide—dilated cardiomyopathy	0.083	0.0984	CbGbCtD
Hydroflumethiazide—CA12—Furosemide—dilated cardiomyopathy	0.083	0.0984	CbGbCtD
Hydroflumethiazide—CA1—Furosemide—dilated cardiomyopathy	0.0776	0.092	CbGbCtD
Hydroflumethiazide—CA4—Furosemide—dilated cardiomyopathy	0.073	0.0865	CbGbCtD
Hydroflumethiazide—CA2—Furosemide—dilated cardiomyopathy	0.0671	0.0795	CbGbCtD
Hydroflumethiazide—CA5B—sinoatrial node—dilated cardiomyopathy	0.0204	0.389	CbGeAlD
Hydroflumethiazide—KCNMA1—pulmonary artery—dilated cardiomyopathy	0.0101	0.193	CbGeAlD
Hydroflumethiazide—Angiitis necrotising—Furosemide—dilated cardiomyopathy	0.00996	0.096	CcSEcCtD
Hydroflumethiazide—Xanthopsia—Furosemide—dilated cardiomyopathy	0.00996	0.096	CcSEcCtD
Hydroflumethiazide—Vasculitis necrotising—Furosemide—dilated cardiomyopathy	0.00868	0.0836	CcSEcCtD
Hydroflumethiazide—Gastric irritation—Furosemide—dilated cardiomyopathy	0.00469	0.0452	CcSEcCtD
Hydroflumethiazide—Epigastric discomfort—Furosemide—dilated cardiomyopathy	0.00346	0.0333	CcSEcCtD
Hydroflumethiazide—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00343	0.033	CcSEcCtD
Hydroflumethiazide—CA14—cardiac ventricle—dilated cardiomyopathy	0.00259	0.0494	CbGeAlD
Hydroflumethiazide—Glycosuria—Furosemide—dilated cardiomyopathy	0.00225	0.0216	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00219	0.0211	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00207	0.0199	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00196	0.0189	CcSEcCtD
Hydroflumethiazide—Vasculitis—Furosemide—dilated cardiomyopathy	0.00186	0.018	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00185	0.0178	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00175	0.0168	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00171	0.0165	CcSEcCtD
Hydroflumethiazide—CA14—heart—dilated cardiomyopathy	0.0017	0.0324	CbGeAlD
Hydroflumethiazide—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00155	0.015	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Furosemide—dilated cardiomyopathy	0.0015	0.0145	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00148	0.0142	CcSEcCtD
Hydroflumethiazide—CA14—cardiac atrium—dilated cardiomyopathy	0.00146	0.0277	CbGeAlD
Hydroflumethiazide—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00141	0.0135	CcSEcCtD
Hydroflumethiazide—Vasculitis—Lisinopril—dilated cardiomyopathy	0.0014	0.0135	CcSEcCtD
Hydroflumethiazide—KCNMA1—heart—dilated cardiomyopathy	0.00138	0.0264	CbGeAlD
Hydroflumethiazide—Purpura—Furosemide—dilated cardiomyopathy	0.00137	0.0132	CcSEcCtD
Hydroflumethiazide—ATP1A1—cardiac ventricle—dilated cardiomyopathy	0.00135	0.0258	CbGeAlD
Hydroflumethiazide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00131	0.0126	CcSEcCtD
Hydroflumethiazide—ATP1A1—myocardium—dilated cardiomyopathy	0.00127	0.0243	CbGeAlD
Hydroflumethiazide—CA4—cardiac ventricle—dilated cardiomyopathy	0.00125	0.0239	CbGeAlD
Hydroflumethiazide—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00121	0.0116	CcSEcCtD
Hydroflumethiazide—CA5B—heart—dilated cardiomyopathy	0.00119	0.0227	CbGeAlD
Hydroflumethiazide—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00119	0.0115	CcSEcCtD
Hydroflumethiazide—CA4—myocardium—dilated cardiomyopathy	0.00118	0.0224	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00117	0.0113	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00113	0.0109	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00112	0.0108	CcSEcCtD
Hydroflumethiazide—CA1—heart—dilated cardiomyopathy	0.00105	0.02	CbGeAlD
Hydroflumethiazide—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00104	0.01	CcSEcCtD
Hydroflumethiazide—CA2—cardiac ventricle—dilated cardiomyopathy	0.00104	0.0198	CbGeAlD
Hydroflumethiazide—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00103	0.00992	CcSEcCtD
Hydroflumethiazide—CA5B—cardiac atrium—dilated cardiomyopathy	0.00102	0.0194	CbGeAlD
Hydroflumethiazide—CA2—myocardium—dilated cardiomyopathy	0.000976	0.0186	CbGeAlD
Hydroflumethiazide—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00095	0.00915	CcSEcCtD
Hydroflumethiazide—Urticaria—Spironolactone—dilated cardiomyopathy	0.000948	0.00913	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000905	0.00872	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000892	0.00859	CcSEcCtD
Hydroflumethiazide—ATP1A1—heart—dilated cardiomyopathy	0.000889	0.0169	CbGeAlD
Hydroflumethiazide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000879	0.00847	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00084	0.00809	CcSEcCtD
Hydroflumethiazide—CA4—heart—dilated cardiomyopathy	0.000822	0.0157	CbGeAlD
Hydroflumethiazide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000816	0.00786	CcSEcCtD
Hydroflumethiazide—Dizziness—Spironolactone—dilated cardiomyopathy	0.000789	0.0076	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000782	0.00753	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000773	0.00744	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000765	0.00737	CcSEcCtD
Hydroflumethiazide—ATP1A1—cardiac atrium—dilated cardiomyopathy	0.000761	0.0145	CbGeAlD
Hydroflumethiazide—Vomiting—Spironolactone—dilated cardiomyopathy	0.000759	0.00731	CcSEcCtD
Hydroflumethiazide—Rash—Spironolactone—dilated cardiomyopathy	0.000752	0.00725	CcSEcCtD
Hydroflumethiazide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000752	0.00724	CcSEcCtD
Hydroflumethiazide—Headache—Spironolactone—dilated cardiomyopathy	0.000748	0.0072	CcSEcCtD
Hydroflumethiazide—Jaundice—Lisinopril—dilated cardiomyopathy	0.000744	0.00717	CcSEcCtD
Hydroflumethiazide—Agitation—Furosemide—dilated cardiomyopathy	0.000731	0.00704	CcSEcCtD
Hydroflumethiazide—Vertigo—Furosemide—dilated cardiomyopathy	0.000715	0.00688	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000713	0.00686	CcSEcCtD
Hydroflumethiazide—Leukopenia—Furosemide—dilated cardiomyopathy	0.000712	0.00686	CcSEcCtD
Hydroflumethiazide—Nausea—Spironolactone—dilated cardiomyopathy	0.000709	0.00683	CcSEcCtD
Hydroflumethiazide—CA4—cardiac atrium—dilated cardiomyopathy	0.000703	0.0134	CbGeAlD
Hydroflumethiazide—CA2—heart—dilated cardiomyopathy	0.000682	0.013	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000636	0.00612	CcSEcCtD
Hydroflumethiazide—Anorexia—Furosemide—dilated cardiomyopathy	0.000619	0.00596	CcSEcCtD
Hydroflumethiazide—CA2—cardiac atrium—dilated cardiomyopathy	0.000583	0.0111	CbGeAlD
Hydroflumethiazide—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000574	0.00553	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000564	0.00544	CcSEcCtD
Hydroflumethiazide—Constipation—Furosemide—dilated cardiomyopathy	0.000555	0.00535	CcSEcCtD
Hydroflumethiazide—Vertigo—Lisinopril—dilated cardiomyopathy	0.000536	0.00516	CcSEcCtD
Hydroflumethiazide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000534	0.00515	CcSEcCtD
Hydroflumethiazide—Urticaria—Furosemide—dilated cardiomyopathy	0.000516	0.00497	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000478	0.00461	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000477	0.00459	CcSEcCtD
Hydroflumethiazide—Asthenia—Furosemide—dilated cardiomyopathy	0.000466	0.00449	CcSEcCtD
Hydroflumethiazide—Anorexia—Lisinopril—dilated cardiomyopathy	0.000464	0.00447	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000444	0.00428	CcSEcCtD
Hydroflumethiazide—Dizziness—Furosemide—dilated cardiomyopathy	0.000429	0.00413	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000423	0.00408	CcSEcCtD
Hydroflumethiazide—Constipation—Lisinopril—dilated cardiomyopathy	0.000417	0.00401	CcSEcCtD
Hydroflumethiazide—Vomiting—Furosemide—dilated cardiomyopathy	0.000413	0.00398	CcSEcCtD
Hydroflumethiazide—Rash—Furosemide—dilated cardiomyopathy	0.000409	0.00394	CcSEcCtD
Hydroflumethiazide—Dermatitis—Furosemide—dilated cardiomyopathy	0.000409	0.00394	CcSEcCtD
Hydroflumethiazide—Headache—Furosemide—dilated cardiomyopathy	0.000407	0.00392	CcSEcCtD
Hydroflumethiazide—Urticaria—Lisinopril—dilated cardiomyopathy	0.000387	0.00373	CcSEcCtD
Hydroflumethiazide—Nausea—Furosemide—dilated cardiomyopathy	0.000386	0.00371	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000359	0.00346	CcSEcCtD
Hydroflumethiazide—Asthenia—Lisinopril—dilated cardiomyopathy	0.000349	0.00337	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000333	0.00321	CcSEcCtD
Hydroflumethiazide—Dizziness—Lisinopril—dilated cardiomyopathy	0.000322	0.0031	CcSEcCtD
Hydroflumethiazide—Vomiting—Lisinopril—dilated cardiomyopathy	0.00031	0.00298	CcSEcCtD
Hydroflumethiazide—Rash—Lisinopril—dilated cardiomyopathy	0.000307	0.00296	CcSEcCtD
Hydroflumethiazide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000307	0.00296	CcSEcCtD
Hydroflumethiazide—Headache—Lisinopril—dilated cardiomyopathy	0.000305	0.00294	CcSEcCtD
Hydroflumethiazide—Nausea—Lisinopril—dilated cardiomyopathy	0.000289	0.00279	CcSEcCtD
